gliclazide and s-nitro-n-acetylpenicillamine

gliclazide has been researched along with s-nitro-n-acetylpenicillamine in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahluwalia, A; Chauhan, S; Scotland, RS; Vallance, PJ1

Other Studies

1 other study(ies) available for gliclazide and s-nitro-n-acetylpenicillamine

ArticleYear
An endothelium-derived hyperpolarizing factor-like factor moderates myogenic constriction of mesenteric resistance arteries in the absence of endothelial nitric oxide synthase-derived nitric oxide.
    Hypertension (Dallas, Tex. : 1979), 2001, Volume: 38, Issue:4

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Apamin; Barium; Biological Factors; Calcium; Charybdotoxin; Endothelium, Vascular; Enzyme Inhibitors; Female; Genotype; Glycyrrhetinic Acid; In Vitro Techniques; Indomethacin; Male; Mesenteric Arteries; Mice; Mice, Inbred C57BL; Mice, Knockout; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Penicillamine; Potassium Channel Blockers; Vascular Resistance; Vasoconstriction; Vasoconstrictor Agents

2001